Omicron 20-30% more infectious: INSACOG to review data of Covid variants

Amid rising COVID cases in the national capital and other States, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) will review the data of genomic surveillance of COVID-19 variants

coronavirus
Photo: PTI
ANI General News
2 min read Last Updated : Aug 12 2022 | 7:00 AM IST

Amid rising COVID cases in the national capital and other States, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) will review the data of genomic surveillance of COVID-19 variants on Friday, said sources.

The different strains of Omicron are circulating all over including the national capital, these strains are 20-30 per cent more infectious than the original Omicron virus.

"The current strains that are doing rounds all over are 20-30 per cent more infectious than Omicron sub-variants, but hospitalisation and deaths are still low," said Dr NK Arora, Chairperson of COVID working group National Technical Advisory Group on Immunisation (NTAGI).

"These sub-variants are BA.4, BA.5, BA.2.75, BA.2.38, however, any surge in hospitalization or any disease severity has not been observed so far," said Dr Arora.

According to the bulletin issued on July 11 by INSACOG, Omicron and its sub-lineages continue to be the dominant variant in India.

"BA.2.75 sub-variant has acquired more mutations in spike protein and other genes of the SARS-CoV-2 and it also mentioned that the variant is being closely monitored," he said.

INSACOG is jointly initiated by the Union Health Ministry of Health and the Department of Biotechnology (DBT) with the Council for Scientific and Industrial Research (CSIR) and the Indian Council of Medical Research (ICMR)

Delhi on Thursday reported 2,726 fresh COVID-19 cases and six fatalities in the last 24 hours. the positivity rate is currently at 14.38 per cent.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronCoronavirus Testshealth care

First Published: Aug 12 2022 | 7:00 AM IST

Next Story